KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the...
KORU Medical bylaw change vests director removal power solely with majority shareholders
Repro-Med Systems Earnings Call Signals Renewed Momentum
KORU Medical forecasts FY2026 revenue of $47.5 million-$48.5 million
KORU Medical Systems (NASDAQ:KRMD) Announces Quarterly Earnings Results
KORU Medical | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 12.05 M
KORU Medical Q2 FY26 net income turns to profit at $252,449; revenue rises 18% to $12 million